Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Correction to: A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB.

Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW.

Eur J Nucl Med Mol Imaging. 2020 Feb 13. doi: 10.1007/s00259-020-04692-3. [Epub ahead of print]

PMID:
32055964
2.

Tuning Butyrylcholinesterase Inactivation and Reactivation by Polymer-Based Protein Engineering.

Zhang L, Baker SL, Murata H, Harris N, Ji W, Amitai G, Matyjaszewski K, Russell AJ.

Adv Sci (Weinh). 2019 Nov 13;7(1):1901904. doi: 10.1002/advs.201901904. eCollection 2020 Jan.

3.

Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults.

Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ.

Eur J Nucl Med Mol Imaging. 2020 Jan 8. doi: 10.1007/s00259-019-04669-x. [Epub ahead of print]

PMID:
31915896
4.

Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.

La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O'Neil JP, Pham J, Rojas JC, Rosen HJ, Seeley WW, Tsai RM, Miller BL, Jagust WJ, Rabinovici GD.

Sci Transl Med. 2020 Jan 1;12(524). pii: eaau5732. doi: 10.1126/scitranslmed.aau5732.

PMID:
31894103
5.

A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB.

Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW.

Eur J Nucl Med Mol Imaging. 2019 Dec 13. doi: 10.1007/s00259-019-04596-x. [Epub ahead of print] Erratum in: Eur J Nucl Med Mol Imaging. 2020 Feb 13;:.

PMID:
31834446
6.

Structure-function-dynamics of α-chymotrypsin based conjugates as a function of polymer charge.

Munasinghe A, Baker SL, Lin P, Russell AJ, Colina CM.

Soft Matter. 2020 Jan 2;16(2):456-465. doi: 10.1039/c9sm01842e.

PMID:
31803897
7.

Atom Transfer Radical Polymerization for Biorelated Hybrid Materials.

Baker SL, Kaupbayeva B, Lathwal S, Das SR, Russell AJ, Matyjaszewski K.

Biomacromolecules. 2019 Dec 9;20(12):4272-4298. doi: 10.1021/acs.biomac.9b01271. Epub 2019 Nov 18.

PMID:
31738532
8.

Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy.

Lesman-Segev OH, La Joie R, Stephens ML, Sonni I, Tsai R, Bourakova V, Visani AV, Edwards L, O'Neil JP, Baker SL, Gardner RC, Janabi M, Chaudhary K, Perry DC, Kramer JH, Miller BL, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2019;24:102025. doi: 10.1016/j.nicl.2019.102025. Epub 2019 Oct 17.

9.

Erythrocytes as carriers of immunoglobulin-based therapeutics.

Ji W, Smith PN, Koepsel RR, Andersen JD, Baker SL, Zhang L, Carmali S, Myerson JW, Muzykantov V, Russell AJ.

Acta Biomater. 2020 Jan 1;101:422-435. doi: 10.1016/j.actbio.2019.10.027. Epub 2019 Oct 25.

PMID:
31669698
10.

Tau deposition is associated with functional isolation of the hippocampus in aging.

Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ.

Nat Commun. 2019 Oct 25;10(1):4900. doi: 10.1038/s41467-019-12921-z.

11.

Transforming protein-polymer conjugate purification by tuning protein solubility.

Baker SL, Munasinghe A, Kaupbayeva B, Rebecca Kang N, Certiat M, Murata H, Matyjaszewski K, Lin P, Colina CM, Russell AJ.

Nat Commun. 2019 Oct 17;10(1):4718. doi: 10.1038/s41467-019-12612-9.

12.

Cortical tau deposition follows patterns of entorhinal functional connectivity in aging.

Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ.

Elife. 2019 Sep 2;8. pii: e49132. doi: 10.7554/eLife.49132.

13.

Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain.

Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP.

J Neurosci. 2019 Aug 7;39(32):6315-6324. doi: 10.1523/JNEUROSCI.0503-19.2019. Epub 2019 Jun 17.

14.

The relationship between domain-specific subjective cognitive decline and Alzheimer's pathology in normal elderly adults.

Shokouhi S, Conley AC, Baker SL, Albert K, Kang H, Gwirtsman HE, Newhouse PA; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2019 Sep;81:22-29. doi: 10.1016/j.neurobiolaging.2019.05.011. Epub 2019 May 23.

PMID:
31207466
15.

Endothelial glycocalyx restoration by growth factors in diabetic nephropathy.

Desideri S, Onions KL, Baker SL, Gamez M, El Hegni E Hussien H, Russell A, Satchell SC, Foster RR.

Biorheology. 2019;56(2-3):163-179. doi: 10.3233/BIR-180199.

PMID:
31156139
16.

Charge-Preserving Atom Transfer Radical Polymerization Initiator Rescues the Lost Function of Negatively Charged Protein-Polymer Conjugates.

Baker SL, Murata H, Kaupbayeva B, Tasbolat A, Matyjaszewski K, Russell AJ.

Biomacromolecules. 2019 Jun 10;20(6):2392-2405. doi: 10.1021/acs.biomac.9b00379. Epub 2019 May 22.

PMID:
31079461
17.

Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain.

Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2019;23:101848. doi: 10.1016/j.nicl.2019.101848. Epub 2019 May 2.

18.

Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span.

Baker SL, Harrison TM, Maass A, La Joie R, Jagust WJ.

J Nucl Med. 2019 Oct;60(10):1444-1451. doi: 10.2967/jnumed.118.224113. Epub 2019 Mar 15.

19.

Longitudinal tau accumulation and atrophy in aging and alzheimer disease.

Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, Mellinger TJ, Edwards L, Pham J, Miller BL, Rabinovici GD, Jagust WJ.

Ann Neurol. 2019 Feb;85(2):229-240. doi: 10.1002/ana.25406. Epub 2019 Jan 17.

20.

'It's like you don't have a roadmap really': using an antiracism framework to analyze patients' encounters in the cancer system.

Black KZ, Lightfoot AF, Schaal JC, Mouw MS, Yongue C, Samuel CA, Faustin YF, Ackert KL, Akins B, Baker SL, Foley K, Hilton AR, Mann-Jackson L, Robertson LB, Shin JY, Yonas M, Eng E.

Ethn Health. 2018 Dec 13:1-21. doi: 10.1080/13557858.2018.1557114. [Epub ahead of print]

PMID:
30543116
21.

VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy.

Onions KL, Gamez M, Buckner NR, Baker SL, Betteridge KB, Desideri S, Dallyn BP, Ramnath RD, Neal CR, Farmer LK, Mathieson PW, Gnudi L, Alitalo K, Bates DO, Salmon AHJ, Welsh GI, Satchell SC, Foster RR.

Diabetes. 2019 Jan;68(1):172-187. doi: 10.2337/db18-0045. Epub 2018 Nov 2.

22.

Keel bone differences in laying hens housed in enriched colony cages.

Chargo NJ, Robison CI, Akaeze HO, Baker SL, Toscano MJ, Makagon MM, Karcher DM.

Poult Sci. 2019 Feb 1;98(2):1031-1036. doi: 10.3382/ps/pey421.

23.

Scan-Time Corrections for 80-100-min Standardizetd Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging.

He M, Baker SL, Shah VD, Lockhart SN, Jagust WJ.

IEEE Trans Med Imaging. 2019 Mar;38(3):697-709. doi: 10.1109/TMI.2018.2870441. Epub 2018 Sep 17.

24.

Keel bone damage assessment: consistency in enriched colony laying hens.

Chargo NJ, Robison CI, Baker SL, Toscano MJ, Makagon MM, Karcher DM.

Poult Sci. 2019 Feb 1;98(2):1017-1022. doi: 10.3382/ps/pey373.

25.

Intramolecular Interactions of Conjugated Polymers Mimic Molecular Chaperones to Stabilize Protein-Polymer Conjugates.

Baker SL, Munasinghe A, Murata H, Lin P, Matyjaszewski K, Colina CM, Russell AJ.

Biomacromolecules. 2018 Sep 10;19(9):3798-3813. doi: 10.1021/acs.biomac.8b00927. Epub 2018 Aug 22.

PMID:
30086223
26.

Effects of combined pre- and post-natal enrichment on anxiety-like, social, and cognitive behaviours in juvenile and adult rat offspring.

Sparling JE, Baker SL, Bielajew C.

Behav Brain Res. 2018 Nov 1;353:40-50. doi: 10.1016/j.bbr.2018.06.033. Epub 2018 Jun 30.

PMID:
29966601
27.

Brain morphology, cognition, and β-amyloid in older adults with superior memory performance.

Harrison TM, Maass A, Baker SL, Jagust WJ.

Neurobiol Aging. 2018 Jul;67:162-170. doi: 10.1016/j.neurobiolaging.2018.03.024. Epub 2018 Mar 27.

28.

Solid-phase synthesis of protein-polymers on reversible immobilization supports.

Murata H, Carmali S, Baker SL, Matyjaszewski K, Russell AJ.

Nat Commun. 2018 Feb 27;9(1):845. doi: 10.1038/s41467-018-03153-8.

29.

Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.

La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, Rosen HJ, Tsai R, Visani AV, Miller BL, Jagust WJ, Rabinovici GD.

Neurology. 2018 Jan 23;90(4):e282-e290. doi: 10.1212/WNL.0000000000004860. Epub 2017 Dec 27.

30.

Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.

Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ.

JAMA Neurol. 2018 Feb 1;75(2):227-235. doi: 10.1001/jamaneurol.2017.3713.

31.

Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.

Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust WJ.

J Neurosci. 2018 Jan 17;38(3):530-543. doi: 10.1523/JNEUROSCI.2028-17.2017. Epub 2017 Nov 30.

32.

Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease.

Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2017 Sep 25;17:452-464. doi: 10.1016/j.nicl.2017.09.016. eCollection 2018.

33.

Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data.

Baker SL, Maass A, Jagust WJ.

Data Brief. 2017 Oct 16;15:648-657. doi: 10.1016/j.dib.2017.10.024. eCollection 2017 Dec.

34.

Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD.

Brain. 2017 Dec 1;140(12):3286-3300. doi: 10.1093/brain/awx243.

35.

18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.

Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD Sr, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD.

Ann Neurol. 2017 Oct;82(4):622-634. doi: 10.1002/ana.25060.

36.

Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.

Berry AS, Shah VD, Furman DJ, White RL 3rd, Baker SL, O'Neil JP, Janabi M, D'Esposito M, Jagust WJ.

Neuropsychopharmacology. 2018 May;43(6):1201-1211. doi: 10.1038/npp.2017.180. Epub 2017 Aug 17.

37.

Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.

Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La Joie R, Rabinovici GD, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.

38.

A system for coordinated analysis of translational readthrough and nonsense-mediated mRNA decay.

Baker SL, Hogg JR.

PLoS One. 2017 Mar 21;12(3):e0173980. doi: 10.1371/journal.pone.0173980. eCollection 2017.

39.

Amyloid and tau PET demonstrate region-specific associations in normal older people.

Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ.

Neuroimage. 2017 Apr 15;150:191-199. doi: 10.1016/j.neuroimage.2017.02.051. Epub 2017 Feb 21.

40.

Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging.

Marks SM, Lockhart SN, Baker SL, Jagust WJ.

J Neurosci. 2017 Mar 22;37(12):3192-3201. doi: 10.1523/JNEUROSCI.3769-16.2017. Epub 2017 Feb 17.

41.

Design of Stomach Acid-Stable and Mucin-Binding Enzyme Polymer Conjugates.

Cummings CS, Campbell AS, Baker SL, Carmali S, Murata H, Russell AJ.

Biomacromolecules. 2017 Feb 13;18(2):576-586. doi: 10.1021/acs.biomac.6b01723. Epub 2017 Jan 31.

PMID:
28081602
42.

Aging Affects Dopaminergic Neural Mechanisms of Cognitive Flexibility.

Berry AS, Shah VD, Baker SL, Vogel JW, O'Neil JP, Janabi M, Schwimmer HD, Marks SM, Jagust WJ.

J Neurosci. 2016 Dec 14;36(50):12559-12569. Epub 2016 Nov 2.

43.

Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.

Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ.

J Nucl Med. 2017 Feb;58(2):332-338. doi: 10.2967/jnumed.116.175273. Epub 2016 Sep 1.

44.

Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.

Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ.

PLoS One. 2016 Jun 29;11(6):e0158460. doi: 10.1371/journal.pone.0158460. eCollection 2016.

45.

Structural basis of suppression of host translation termination by Moloney Murine Leukemia Virus.

Tang X, Zhu Y, Baker SL, Bowler MW, Chen BJ, Chen C, Hogg JR, Goff SP, Song H.

Nat Commun. 2016 Jun 22;7:12070. doi: 10.1038/ncomms12070.

46.

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD.

Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8.

47.

PET Imaging of Tau Deposition in the Aging Human Brain.

Schöll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ.

Neuron. 2016 Mar 2;89(5):971-982. doi: 10.1016/j.neuron.2016.01.028.

48.

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment.

Shokouhi S, Mckay JW, Baker SL, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2016 Jan 15;8:2. doi: 10.1186/s13195-016-0172-3.

49.

Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography.

Boutchko R, Mitra D, Baker SL, Jagust WJ, Gullberg GT.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1104-11. doi: 10.1038/jcbfm.2015.69. Epub 2015 Apr 22.

50.

Effect of 6-minute colonoscopy withdrawal time policy on polyp detection rate in a community hospital.

Baker SL, Miller RA, Creighton A, Aguilar PS.

Gastroenterol Nurs. 2015 Mar-Apr;38(2):96-9. doi: 10.1097/SGA.0000000000000094.

PMID:
25831245

Supplemental Content

Loading ...
Support Center